simvastatin has been researched along with Biliary Cirrhosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callender, ME; Cash, WJ; McCance, DR; McDougall, NI; McEneny, J; O'Donnell, ME; O'Neill, S; Young, IS | 1 |
| Claudel, T; Stojakovic, T; Trauner, M | 1 |
| Han, JH; Jang, HK; Kim, CH; Kim, DG; Kim, Y; Lee, EJ; Park, SM | 1 |
| Abraldes, JG; Bosch, J; García-Calderó, H; García-Pagán, JC; Gracia-Sancho, J; Lozano, JJ; Meireles, CZ; Pasarin, M | 1 |
| Adachi, Y; Kamisako, T | 1 |
| Amati, B; Crosignani, A; Del Puppo, M; Galli Kienle, M; Petroni, ML; Podda, M; Zuin, M | 1 |
| Armstrong, VW; Leonhardt, U; Näther, M; Ramadori, G; Ritzel, U; Schäfer, G | 1 |
2 trial(s) available for simvastatin and Biliary Cirrhosis
| Article | Year |
|---|---|
Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis.
Topics: Ascorbic Acid; Biomarkers; Cholesterol; Endothelium, Vascular; Female; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Inflammation Mediators; Lipid Peroxides; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Northern Ireland; Pulse Wave Analysis; Simvastatin; Single-Blind Method; Time Factors; Treatment Outcome; Vascular Stiffness | 2013 |
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.
Topics: Aged; Anticholesteremic Agents; Cholagogues and Choleretics; Cholesterol; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Simvastatin; Ursodeoxycholic Acid | 2001 |
5 other study(ies) available for simvastatin and Biliary Cirrhosis
| Article | Year |
|---|---|
Editorial for 'randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis'.
Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirrhosis, Biliary; Male; Simvastatin | 2014 |
Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
Topics: Bile Ducts; Biomarkers; Cell Line, Transformed; Cell Proliferation; Cytoprotection; Down-Regulation; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Cirrhosis, Biliary; NF-kappa B; Phosphorylation; Signal Transduction; Simvastatin; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta1 | 2016 |
Simvastatin Attenuates Liver Injury in Rodents with Biliary Cirrhosis Submitted to Hemorrhage/Resuscitation.
Topics: Animals; Gastrointestinal Hemorrhage; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Rats; Simvastatin | 2017 |
Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.
Topics: Adult; Anticholesteremic Agents; Cholestasis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Lovastatin; Simvastatin | 1995 |
Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Cholesterol; Cholesterol, LDL; Female; gamma-Glutamyltransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Immunoglobulin M; Lipids; Liver Cirrhosis, Biliary; Middle Aged; Simvastatin | 2002 |